Key result
Higher estimated pulse-wave velocity was an independent predictor of reduced survival-to-discharge in patients requiring extracorporeal membrane oxygenation (OR 0.70, p=0.00021).
Why the study?
Arterial stiffness measured by estimated pulse-wave velocity predicts MACE, but its predictive value in patients requiring ECMO is unknown.
Does estimated pulse-wave velocity predict survival-to-discharge in patients requiring extracorporeal membrane oxygenation?
Cohort (n=255)
No
Does estimated pulse-wave velocity predict survival-to-discharge in patients requiring extracorporeal membrane oxygenation?
Odds Ratio: 0.7
p-value: p=0.00021
Estimated pulse-wave velocity is an independent predictor of survival-to-discharge and ischemic stroke in patients requiring ECMO, suggesting its potential utility for risk stratification.
Introduction Arterial stiffness, measured by estimated pulse-wave velocity is a known predictor of major adverse cardiovascular events, however its predictive value in patients requiring extracorporeal membrane oxygenation (ECMO) is unknown. Methods A retrospective cohort study was performed at the London Health Science Centre in London, Canada between 1996–2021, totaling 255 patients requiring ECMO. Estimated pulse-wave velocity (ePWV) was calculated using an algorithm from the Reference Values for Arterial Stiffness Collaboration. Recorded outcomes included in-hospital death, ischemic stroke, hemorrhagic stroke, renal failure and need for renal replacement therapy (RRT). For adjusted analysis, survival-to-discharge was used. Multivariate logistic regression and propensity-score matching were utilized to control for confounding. Results On univariate analysis, higher ePWV was significantly predictive of ischemic stroke (OR 1.676, p = 0.0002) and in-hospital death (OR 1.20, p = 0.006), but insignificant for predicting hemorrhagic stroke (OR 1.07, p = 0.710), and appeared protective for renal failure (OR 0.88 [0.78–0.99], p = 0.034) and RRT (OR 0.87, p = 0.027). On multivariate analysis and propensity-score matching, five of six models demonstrated ePWV as an independent predictor of survival-to-discharge. (OR 0.70, p = 0.00,021; OR 0.72, p = 0.0002; OR 0.87, p = 0.045; OR 0.85, p = 0.013; OR 0.57, p = 0.012) Conclusions ePWV is a promising marker for risk-stratification in ECMO patients. Further investigation is required to better delineate the role of arterial health assessment in disease trajectory and strengthen the validity of AS as a marker of interest in medical and surgical management.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2022) conducted a cohort in Extracorporeal membrane oxygenation (ECMO) requirement (n=255). Estimated pulse-wave velocity (ePWV) was evaluated on Survival-to-discharge (OR 0.70, p=0.00021). Higher estimated pulse-wave velocity was an independent predictor of reduced survival-to-discharge in patients requiring extracorporeal membrane oxygenation (OR 0.70, p=0.00021).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: